1. Antisense oligodeoxynucleotide therapy for bladder cancer: recent advances and future prospects. Issue 6 (December 2005) Authors: Miyake, Hideaki; Hara, Isao; Fujisaw, Masato; Gleave, Martin E Journal: Expert review of anticancer therapy Issue: Volume 5:Issue 6(2005) Page Start: 1001 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical and molecular features of treatment‐related neuroendocrine prostate cancer. (3rd February 2018) Authors: Akamatsu, Shusuke; Inoue, Takahiro; Ogawa, Osamu; Gleave, Martin E Journal: International journal of urology Issue: Volume 25:Number 4(2018) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clusterin regulates macrophage expansion, polarization and phagocytic activity in response to inflammation in the kidneys. Issue 3 (16th October 2020) Authors: Weng, Xiaodong; Zhao, Haimei; Guan, Qiunong; Shi, Ganggang; Feng, Shijian; Gleave, Martin E; Nguan, Christopher CY; Du, Caigan Journal: Immunology and cell biology Issue: Volume 99:Issue 3(2021) Page Start: 274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Co‐targeting driver pathways in prostate cancer: two birds with one stone. Issue 4 (25th March 2018) Authors: Zoubeidi, Amina; Gleave, Martin E Journal: EMBO molecular medicine Issue: Volume 10:Issue 4(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Frequency of the TMPRSS2:ERG gene fusion is increased in moderate to poorly differentiated prostate cancers. Issue 11 (26th January 2007) Authors: Rajput, Ashish B; Miller, Melinda A; De Luca, Alessandro; Boyd, Niki; Leung, Sam; Hurtado-Coll, Antonio; Fazli, Ladan; Jones, Edward C; Palmer, Jodie B; Gleave, Martin E; Cox, Michael E; Huntsman, David G Journal: Journal of clinical pathology Issue: Volume 60:Issue 11(2007) Page Start: 1238 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Novel targeted agents on the horizon for castration-resistant prostate cancer. (December 2010) Authors: Koupparis, Anthony; Casey, Rowan; Robinson, Michael; Gleave, Martin E Journal: Future oncology Issue: Volume 6:Number 12(2010) Page Start: 1883 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial. Issue 12 (December 2019) Authors: Khalaf, Daniel J; Annala, Matti; Taavitsainen, Sinja; Finch, Daygen L; Oja, Conrad; Vergidis, Joanna; Zulfiqar, Muhammad; Sunderland, Katherine; Azad, Arun A; Kollmannsberger, Christian K; Eigl, Bernhard J; Noonan, Krista; Wadhwa, Deepa; Attwell, Andrew; Keith, Bruce; Ellard, Susan L; Le, Lyly; G... Journal: Lancet oncology Issue: Volume 20:Issue 12(2019) Page Start: 1730 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. PARP inhibition in castration-resistant prostate cancer. (March 2016) Authors: Nappi, Lucia; Gleave, Martin E Journal: Future oncology Issue: Volume 12:Number 5(2016) Page Start: 577 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SEMA3C drives cancer growth by transactivating multiple receptor tyrosine kinases via Plexin B1. Issue 2 (18th January 2018) Authors: Peacock, James W; Takeuchi, Ario; Hayashi, Norihiro; Liu, Liangliang; Tam, Kevin J; Al Nakouzi, Nader; Khazamipour, Nastaran; Tombe, Tabitha; Dejima, Takashi; Lee, Kevin CK; Shiota, Masaki; Thaper, Daksh; Lee, Wilson CW; Hui, Daniel HF; Kuruma, Hidetoshi; Ivanova, Larissa; Yenki, Parvin; Jiao, Iv... Journal: EMBO molecular medicine Issue: Volume 10:Issue 2(2018) Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Targeting the adaptive molecular landscape of castration‐resistant prostate cancer. Issue 7 (20th April 2015) Authors: Wyatt, Alexander W; Gleave, Martin E Journal: EMBO molecular medicine Issue: Volume 7:Issue 7(2015:Jul.) Page Start: 878 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗